BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8442442)

  • 1. Clinton team works with drug companies to expand access, restrict costs.
    Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
    [No Abstract]   [Full Text] [Related]  

  • 2. Study examines weapons in fight to control drug costs.
    Capitation Rates Data; 2001 Apr; 6(4):39-42. PubMed ID: 11330005
    [No Abstract]   [Full Text] [Related]  

  • 3. Lowering the cost of prescription drugs.
    Jindal B
    J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug manufacturers get warning on prices.
    Margolis RE
    Healthspan; 1993 Mar; 10(3):19-20. PubMed ID: 10125344
    [No Abstract]   [Full Text] [Related]  

  • 5. AWP reimbursement scrutinized by several states.
    Carroll J
    Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
    [No Abstract]   [Full Text] [Related]  

  • 6. To cut costs, risky drug use.
    Consum Rep; 2011 Nov; 76(11):9. PubMed ID: 22022754
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription drugs and health care reform.
    Gibaldi M
    Pharmacotherapy; 1993; 13(6):583-9. PubMed ID: 8302681
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlling the cost of prescription drugs.
    White JR
    Health Prog; 1992 Mar; 73(2):12-4, 25. PubMed ID: 10116498
    [No Abstract]   [Full Text] [Related]  

  • 9. [Generic medicines].
    Peláez de Loño J
    Rev Enferm; 1999 Dec; 22(12):836-43. PubMed ID: 10797771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who's really raising drug prices?
    Zagorin A
    Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
    [No Abstract]   [Full Text] [Related]  

  • 11. RX for nosebleed prices.
    Greenwald J
    Time; 2001 May; 157(20):42-3. PubMed ID: 11383109
    [No Abstract]   [Full Text] [Related]  

  • 12. Keeping prescription drugs affordable.
    Arp D
    Healthplan; 2002; 43(6):12-5. PubMed ID: 12506430
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care reform: pharmaceutical industry sees itself as 'whipping boy'.
    Gatty B
    Hosp Formul; 1993 Oct; 28(10):872, 871. PubMed ID: 10129137
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent nonsense: evidence tells of an industry out of social control.
    Mintzberg H
    CMAJ; 2006 Aug; 175(4):374. PubMed ID: 16908900
    [No Abstract]   [Full Text] [Related]  

  • 15. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
    Pinzone JD
    J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.
    Sherrid P
    US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929
    [No Abstract]   [Full Text] [Related]  

  • 17. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rising utilization and costs of prescription drugs.
    PHC4 FYI; 2004; (26):1-2. PubMed ID: 15344277
    [No Abstract]   [Full Text] [Related]  

  • 19. The new drug war.
    Parloff R
    Fortune; 2004 Mar; 149(5):144-6, 148, 150 passim. PubMed ID: 15015428
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.